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Abstract
Background: Mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes (MELAS) is a mitochondrial
cytopathy caused by mutations in mitochondrial DNA. Clinical manifestation is typically before the age of 40.
Case presentation: We present the case of a 63-year-old female in whom the symptoms of MELAS were initially
misdiagnosed as episodes of recurrent ischemic strokes. Brain imaging including MRI, clinical and laboratory findings
that lent cues to the diagnosis of MELAS are discussed. In addition, MRI findings in MELAS in comparison to imaging
mimics of MELAS are presented.
Conclusions: This case underscores the importance of considering MELAS as a potential cause of recurrent stroke-like
events if imaging findings are untypical for cerebral infarction, even among middle-aged patients with vascular risk
factors.
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Background
The clinical syndrome of MELAS (mitochondrial enceph-
alomyopathy, lactic acidosis and stroke-like episodes) is
caused by mutations in mitochondrial deoxyribonucleic
acid (DNA) and subsequent respiratory chain deficiency.
Symptoms and signs typically comprise mitochondrial
myopathy, encephalopathy with stroke-like episodes, sei-
zures and/or dementia, and lactic acidosis [1, 2]. Clinical
manifestation typically occurs before the age of 40 [3]. We
report on a female patient with an unusual clinical mani-
festation of MELAS at 63 years of age.
Case presentation
A 63-year-old woman of short stature was first admitted
to our hospital three days after onset of acute aphasia,
headache and a moderate right-sided hemiparesis. Med-
ical history included type 2 diabetes, arterial hyperten-
sion, and past smoking. The patient had no history of
mental retardation or cognitive decline up to the time of
her acute illness. Whereas childhood and early adult-
hood were reportedly normal, she had developed hearing
loss and diabetes at the age of 45 years. She was also di-
agnosed with cardiomyopathy that was initially thought
to be of hypertensive aetiology, and had a history of
chronic obstructive pulmonary disease (COPD) and
renal insufficiency. Of note, the patient had two miscar-
riages, and one newborn child died within the first hours
after birth. There was no history of previous frequent
headaches. Her medication included aspirin, lercanidi-
pine, candesartan, atorvastatin, fluticasone, salmeterol
and insulin.
On admission, she presented with moderate fluent
aphasia and moderate weakness of the right arm and leg.
Laboratory testing revealed severe hypovolemic hypona-
tremia (116mmol/l) and hyperglycaemia (19mmol/l).
Plasma osmolality was low (284mmol/kg), whereas urine
osmolality (457mmol/kg), and urine sodium concentra-
tion were high (91mmol/l). In addition, serum lactate
(2.7mmol/l), and serum creatine kinase (576 IU/l) levels
were elevated. Computed tomography (CT) on admission
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showed hypodense areas within the left temporal lobe
without signs of haemorrhage. CT angiography showed
few calcified plaques in both carotid bifurcations without
a relevant stenosis or occlusion of intracranial or extracra-
nial arteries (Fig. 1). Emboli detection on transcranial dop-
pler was not performed. Magnetic resonance imaging
(MRI) revealed fluid attenuated inversion recovery
(FLAIR) hyperintensities within the cortical grey and
white matter of the left temporal lobe (Fig. 2). The patient
was diagnosed with ischaemic stroke in the territory of
her left middle cerebral artery and transferred to the
stroke unit. Duplex sonography confirmed moderate ath-
eroma of the right and left carotid bifurcation without
relevant stenosis, which was considered a possible cause.
Transthoracic echocardiography revealed left ventricular
hypertrophy, but no cardiac sources of embolism. Electro-
cardiogram (ECG) monitoring showed no atrial fibrilla-
tion. Glycated haemoglobin was elevated (8.7%). LDL
cholesterol was normal (1.15mmol/l). Antiplatelet therapy
was switched from aspirin to clopidogrel, and the patient
was discharged after two weeks to a neurorehabilitation
hospital with persisting moderate fluent aphasia.
Two weeks later, the patient was readmitted due to re-
currence of the right-sided hemiparesis which now also
involved her face. MRI revealed enlarging FLAIR hyper-
intense signal changes in the mesiotemporal area
extending towards the left parietal lobe and left insula.
In addition, new FLAIR hyperintense signal changes
were also present in the right temporal pole (Fig. 2). CT
angiography again showed no vessel occlusion. The pa-
tient was diagnosed with a recurrent stroke. Holter-ECG
over 4 days did not reveal any atrial fibrillation.
Transoesophageal echocardiography did not reveal any
patent foramen ovale or other cardiac source of embol-
ism, but 4 mm thick plaques in the aorta were visible
which were considered an additional possible cause for
recurrent strokes. Clopidogrel was stopped and oral
anticoagulation with a vitamin K antagonist (Phenpro-
coumon) was started.
During the second hospitalization impaired conscious-
ness, recurrent vomiting and disorientation occurred. Elec-
troencephalography (EEG) showed generalized slowing,
and frequent multifocal rhythmic epileptiform discharges
as well as sharp slow waves as signs of epileptic activity.
Clinical course and EEG findings improved under antiepi-
leptic therapy with lacosamide and levetiracetam. Cerebro-
spinal fluid (CSF) examination revealed normal cell count,
normal protein, negative herpes simplex polymerase chain
reaction (PCR) and elevated lactate levels. Laboratory
screening for vasculitis turned out negative. Considering
the longstanding nicotine abuse and hyponatremia, para-
neoplastic encephalitis was also considered. However, CT
thorax was normal and paraneoplastic antineuronal anti-
bodies in serum (Anti-Hu, Anti-Yo, Anti-Ri, Anti-CV2,
Anti-Ma1, Anti-Ma2/Ta, Anti-Amphiphysin, Anti-VGCC,
and Anti-NMDA-receptor antibodies) turned out negative.
The patient was again discharged with residual aphasia
and was able to return home where she was cared for by
her husband. Six months later, the patient presented at
the emergency department with disorientation, aggres-
sion, mutism and refusal to eat, drink or take her
medication. She was diagnosed with organic psychosis
and admitted to a psychiatric hospital. The patient was
finally readmitted again nine months after initial
Fig. 1 CT angiography (a) and MR-TOF angiography (b) did not reveal any evidence of intracranial arterial stenosis or occlusion
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hospitalization with repeated falls and progressive ap-
athy. On admission, the patient was mutistic.
At this point, MRI showed progressive brain lesions in-
volving both temporal and occipital lobes, characterized by
a FLAIR-hyperintense oedema with signs of a local mass ef-
fect (Fig. 2). Of note, these lesions crossed the boundaries
of vascular territories. The parts of the lesions involving the
cortex appeared hyperintense on diffusion-weighted im-
aging (DWI) and hypointense on apparent diffusion coeffi-
cient (ADC) maps, consistent with cytotoxic oedema. In
contrast, subcortical regions appeared hyperintense on
ADC maps, consistent with vasogenic oedema.
Taking into account the clinical presentation with recur-
rent stroke-like episodes, encephalopathy, seizures, head-
ache and lactic acidosis, as well as the medical history
including hearing loss, short stature, cardiomyopathy and
diabetes, we suspected MELAS as the underlying cause. A
detailed family history revealed hearing loss in a brother,
and transient visual disturbances as well as a history of
acute hearing loss in a sister (Fig. 3).
A biopsy of the vastus lateralis muscle showed signs of
mitochondrial myopathy, including sub-sarcolemmal ac-
cumulation of mitochondria on Gomori trichrome stain-
ing (so-called “ragged red fibers”), neutral fat deposits
and prominent cytochrome C oxidase (COX) negative
and succinate dehydrogenase (SDH) hyperreactive
muscle fibres (Fig. 4). Finally, the diagnosis of MELAS
was confirmed by positive genetic testing for the
m.3243A > G mitochondrial DNA mutation in the
MT-TL1-gene - the most common mutation in patients
with MELAS - in peripheral blood (7% heteroplasmy), as
well as in the muscle biopsy (76% heteroplasmy).
The patient’s state worsened rapidly. The diagnosis
and the lack of curative treatment options were dis-
cussed with her husband, who decided to care of the pa-
tient at home. The patient died shortly thereafter.
Fig. 2 MR imaging findings. Fluid attenuated inversion recovery (FLAIR), diffusion weighted imaging (DWI), and apparent diffusion coefficient
(ADC) images at first presentation and until 9 months later are presented. FLAIR images demonstrate step-wise progressing FLAIR hyperintense
oedema not corresponding to a vascular territory resulting in a local mass effect. DWI delineates both, i) cortical areas of restricted diffusion that
are hyperintense on DWI and hypointense on ADC (arrows), as well as ii) subcortical vasogenic oedema indicated by ADC hyperintense
areas (asterisks)
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Discussion and conclusions
MELAS typically manifests before 40 years of age with
symptoms that may include cardiomyopathy, progressive
(bilateral) sensorineural hearing loss [4], migraine-like
headache, recurrent vomiting, peripheral neuropathy,
ophthalmoplegia, pigmentary retinopathy, diabetes,
hypoparathyroidism, ataxia, and short stature [2]. The
age of the first clinical presentation of stroke-like epi-
sodes in MELAS is highly variable, but first episodes
usually occur before the age of 40. Although MELAS is
a rare disease, the present case illustrates that the clin-
ical presentations and imaging findings may mimic
stroke, the most common acute brain disease. The edu-
cational value of our case lies in distinguishing findings
on brain MRI, which have finally led to the correct
diagnosis.
In our patient, stroke-like episodes first occurred at 63
years of age, which is highly unusual for MELAS. Indeed,
we only found reports on 21 patients with an adult onset
(age > 50 years) in the literature, of whom only 8 were
older than 60 years at first onset of symptoms [5–11]. In-
deed, our patient was misdiagnosed as having recurrent
strokes of arterio-arterial embolic origin. The disease
course, medical history, clinical and paraclinical signs of a
mitochondrial encephalomyopathy [12] and distinct MR
imaging findings finally had led to the suspicion of
MELAS which was confirmed by muscle biopsy and mo-
lecular genetic testing.
The patient’s past medical history and clinical signs in-
cluding short stature, hearing loss, cardiomyopathy, dia-
betes, one death of a newborn child and two miscarriages
were indicative of a mitochondriopathy. In addition, the
patient’s family history revealed two first-degree relatives
with possible oligosymptomatic manifestations of MELAS.
Laboratory findings showed an elevation of serum and
CSF lactate, as well as serum creatine kinase. In addition,
the patient had unexplained hyponatremia [13] which has
Fig. 3 Family history is in alignment with the diagnosis of MELAS. The family tree shows potential oligosymptomatic manifestation in one
brother (hearing loss) and one sister (transitory visual disturbance and acute hearing loss) of our patient
Fig. 4 Cytochrome c oxidase/succinate dehydrogenase (COX/SDH)
double-labelling histochemistry. Staining for SDH and COX revealed
COX negative and SDH hyperreactive muscle fibres indicating
mitochondrial dysfunction. Scale bar: 50 μm
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previously been associated with MELAS [14]. SIADH or
renal impairment have been identified as possible causes
of hyponatremia in MELAS [13, 14]. In our patient, we
suspected a combination of SIADH and hypovolemic
state. Finally, the disease course with step-wise progressive
neurologic deterioration caused by serial stroke-like epi-
sodes was characteristic for the disease.
The reason for the existence of different clinical phe-
notypes with varying age of manifestation is not fully
understood. MELAS is characterized by a high variability
of the mitochondrial mutation load in different individ-
uals of the same affected family, different organs of the
same person, and even in different cells of the same
organ, a phenomenon known as heteroplasmy [15]. This
explains why the disease, which is maternally inherited,
may be missed in family history, why muscle biopsy may
be negative, and why the clinical presentation may not
correlate with molecular findings in blood samples or
tissues [16, 17].
In our patient, distinct findings on brain MRI first
raised the suspicion of MELAS. MELAS lesions are typ-
ically localized in the temporo-occipital cortex and may
progress over time, extending to adjacent areas without
respecting vascular arterial territories [18]. Both grey
and white matter are affected and appear hyperintense
on FLAIR or T2w images as a sign of oedema, which
may result in a pronounced local mass effect [18].
Furthermore, DWI may distinguish different types of
oedema within the same MELAS lesion [19, 20], as was
the case in our patient. A DWI hyperintense signal with
corresponding signal decrease on ADC maps may be ob-
served in the cortical parts of the lesion [21] and signifies
cytotoxic oedema [19, 20, 22]. Of note, the decrease in dif-
fusibility is rather mild when compared to acute ischemia,
and is most likely an expression of a state of reduced cel-
lular energy [22]. In MELAS as in other mitochondrial
encephalomyopathies, respiratory chain deficiency with
impaired oxidative phosphorylation and ATP production
leads to a dysfunction of tissues characterized by a high
demand of oxidative metabolism [21], such as the cardiac
and skeletal muscles, the spiral organ, the brain, peripheral
nerves, and the retina [23]. Cellular loss of energy leads to
decreased activity of the sodium-potassium pump and
other transmembrane pumps or transporters, which in
turn results in cytotoxic oedema and restricted extracellu-
lar diffusion [17, 19, 24, 25]. In addition, neuronal hyper-
excitability causing an energy imbalance which finally
supports cortical necrosis was hypothesized [21]. In con-
trast, normal or even increased diffusion (with a corre-
sponding increase in ADC signal) may be observed in
subcortical areas of the lesion indicating vasogenic
oedema [19, 26]. Gadolinium enhancement may occur in
MELAS lesions, reflecting a breakdown of the blood-brain
barrier. Importantly, new lesions developing during the
clinical course typically exhibit similar morphological fea-
tures as the first one [27].
The imaging features discussed above are not specific
for MELAS, but may help differentiate MELAS lesions
from brain lesions of other cause [28, 29] including sub-
acute ischemic stroke, herpes encephalitis, progressive
multifocal leukoencephalopathy (PML), vasculitis and
posterior reversible encephalopathy syndrome (PRES)
(Fig. 5). Herpes encephalitis, for example, may mimic
MELAS lesions [30] as it typically affects both cortical
and subcortical temporal areas bilaterally, and because
lesions may also exhibit a combination of restricted cor-
tical diffusion and subcortical vasogenic oedema [30].
However, “step-wise” progression of lesions is uncom-
mon in herpes encephalitis, and lesions are typically lo-
cated mesio-temporally [31].
PML is another differential diagnosis presenting with
FLAIR-hyperintense lesions that expand continuously
and centrifugally without respecting vascular territories
[32]. Contrast enhancement may occur as a sign of im-
mune reconstitution inflammatory syndrome (IRIS), and
DWI may again reveal both restricted diffusion at the
edge of PML lesions and hyperdiffusibility in the centre
[32]. In contrast to MELAS, however, cortical areas are
not typically affected in PML, resulting in a “flame-
like” shape of subcortical lesions and a relatively good
signal contrast between the lesion and the cortex [32].
In addition, PML lesions are more often located in the
frontal and parietal lobes or infratentorially and do not
feature a prominent mass effect [32].
Another chameleon mimicking MELAS lesions is pos-
terior reversible encephalopathy syndrome (PRES) [29, 33]
that typically shows vasogenic oedema in subcortical areas
of the occipital and temporal lobes [29, 33]. However,
atypical presentations of PRES are increasingly recognized,
including lesions with signs of restricted cortical diffusion
or lesions in other brain areas [29, 33]. In these cases, clin-
ical features such as the existence of predisposing condi-
tions or the reversibility of symptoms may guide the way
to the correct diagnosis.
Finally, as in our patient, stroke-like episodes in
MELAS can be misdiagnosed as subacute ischemic
strokes. Cerebral infarcts appear as FLAIR-hyperintense
– and sometimes gadolinium-enhancing - lesions involv-
ing the grey and white matter [29]. Cerebral autosomal
dominant arteriopathy with subcortical infarcts and leu-
koencephalopathy (CADASIL) typically presents with re-
current subcortical infarcts and progressive ischemic
white matter lesions predominantly affecting the anterior
temporal pole. Although cortical microinfarcts have
been demonstrated, macroscopic cortical infarcts are
rare in CADASIL [34]. Given the size of the lesions in
our patient, one would, however, expect occlusion or
stenosis of the relevant arteries. More importantly, the
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MELAS lesion is not restricted to vascular territories
and may show, as detailed above, a combination of en-
hanced and mildly restricted diffusion. Both features are
highly uncommon in subacute ischemic infarcts.
Naturally, imaging features must be considered in
the context of the clinical course, which differs mark-
edly between MELAS and some of the causes listed
above.
The final diagnosis in our patient was confirmed
both by histochemical staining of skeletal muscle bi-
opsy and by molecular genetic testing of mitochon-
drial DNA.
Current therapeutic options for MELAS [35, 36] are
limited to supplementation of coenzyme Q10, L-carnitine
and L-arginine, a non-essential amino acid involved in
NO synthesis and endothelial-dependent vascular relax-
ation which may explain its benefit particularly in the
acute phase of the disease [17]. Nonetheless, disability
may progress rapidly and the outcome is often poor [37].
In conclusion, this MELAS case with first stroke-like
episodes at 63 years of age underscores the importance
of considering inherited mitochondrial disorders as a po-
tential cause of recurrent atypical stroke-like events, if
MRI findings are inconsistent with ischemic infarction,
even in adult or elderly patients.
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